USA 512-794-8907 | Canada 902-275-4555

The U.S. National Library of Medicine® (NLM®) provides the the worlds largest online biomedical library.

Under the auspices of the NLM®, the National Center for Biotechnology Information (NCBI) maintains a large collection of scientific and biomedical databases.

The PubMed database contains over 25 million scientific references and citations which are richly indexed and connected by advanced search algorithms. PubMed is also sometimes referred to as, MEDLINE®, and vice-versa. While there are differences between the tow that are important to experts, the two terms are frequently used interchangeably with the most common being the term ‘PubMed’.

PubMed comprises over 25 million citations for biomedical literature from MEDLINE, life science journals, and online books. PubMed citations and abstracts include the fields of biomedicine and health, covering portions of the life sciences, behavioral sciences, chemical sciences, and bioengineering. PubMed also provides access to additional relevant web sites and links to the other NCBI molecular biology resources.

This description is directly from the PubMed website:

“PubMed is a free resource that is developed and maintained by the National Center for Biotechnology Information (NCBI), at the U.S. National Library of Medicine (NLM), located at the National Institutes of Health (NIH).”

PubMed provides quality control in scientific publishing. Only journals that meet PubMed’s scientific standards are indexed. The database is maintained and updated by the National Library of Medicine on a weekly basis.

As of December 2015, PubMed has over 25 million citation records; about 500,000 new records are added each year.

PubMed Central® (PMC) is a free full-text archive of biomedical and life sciences journal literature containing over 3.6 million scientific articles which are free for any user to read, download and store for reference.

This wealth of scholarly knowledge is of significant importance for researchers in making scientific discoveries and healthcare professionals in managing health-related matters.

Dr LaValley has devoted himself to developing methodologies for understanding, search, retrieval, utilization and practical administration of the evidence-based molecularly-targeted data regarding natural product supplements and re-purposed anti-cancer ‘off-label’ prescriptions within PubMed and PubMed Central®.

The Cancer Wellness Plan®MD treatment plan recommendations developed by Dr. LaValley for other doctors’ to have available to administer to their patients are drawn directly from the scientific evidence base accessed through PubMed and PubMed Central®.